Kine Eide Kvitne

Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus

A. Åsberg, A. Hartmann, T. Halden, 2019, Diabetes Care.

Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesity

P. Artursson, E. Skovlund, C. Karlsson, 2022, Clinical and translational science.

Short‐ and long‐term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity

P. Artursson, A. Åsberg, E. Skovlund, 2022, British journal of clinical pharmacology.

Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral Clearance

P. Artursson, E. Skovlund, J. Hjelmesæth, 2023, Clinical Pharmacokinetics.

Response to: “Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time”

E. Molden, Kine Eide Kvitne, Ida Robertsen, 2022, European Journal of Clinical Pharmacology.

Intraindividual Variability in Absolute Bioavailability and Clearance of Midazolam in Healthy Individuals

Eline Skadberg, Kine Eide Kvitne, Ida Robertsen, 2023, Clinical Pharmacokinetics.